Resources

Rare Disease Day on Saturday was a moment to reflect on the momentum building , and to check in on the progress of the UK Rare Disease Framework.

Firefinch Software has joined the Association of British HealthTech Industries (ABHI), aligning its specialist software capabilities with the UK’s leading healthtech network to better support health tech and medical device developers. This milestone coincides with Firefinch’s UK and Europe training roadshow, offering hands on support to teams building compliant software for medical devices.

Located within the Glasgow Riverside Innovation District (GRID), the highly anticipated Health Innovation Hub (HiH) has secured Panthera as a new tenant ahead of its official opening next month.

TechBio’s potential to both transform our sector and provide precision diagnosis and care to patients is well recognised, and TechBio Boost is playing a vital role in scaling companies in this space.

What an incredible night! Last Thursday, we welcomed a record 780 of you to the Roundhouse for the 2026 BIA Gala Dinner. It was a powerful reminder of the strength, resilience and sheer brilliance of our community.

In this blog, Saqib Lal, Head of Content at BIA, reflects on a stellar Gala Dinner. He describes it as a moment to pause and recognise the extraordinary people who make the UK life sciences sector a global powerhouse. This year, as a record 780 guests gathered at the iconic Roundhouse for an evening that demonstrated renewed ambition and positivity. 

With a number of unprecedented leaks, speculation and media briefings indicating potential wide ranging and significant tax rises, in the end the 2025 Autumn Budget seemed to be one of restraint and headline rates remained untouched.

We’re excited to launch She Steers, NEDs in Biotech, a specialist Non-Executive Director (NED) board programme created for women across life sciences and biotech.

This week JPM kicks off in San Francisco with BIA hosting a UK Reception. A significant week for BIA too with the long-awaited announcement of our new CEO.

Pioneer Group has once again teamed up with global biopharmaceutical company AbbVie to launch a Golden Ticket programme designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neurology, eye care, aesthetics, or other specialities including obesity, GI and hepatology.

The Innovation Ecosystem Programme, an 18-month-long NHS England project, which the BIA have been involved in throughout, describes how the UK can lead the way globally in health gains and life sciences powered growth. Its final report was published last week.

PACE has launched its second funding round, with up to £5 million available to support cutting-edge diagnostic projects. This funding is part of a broader £30 million investment to address the global challenge of AMR.

The political party conference season is in full swing, and the BIA is out in force in Liverpool for the Labour Party conference this week. I'm heartened to see the focus in ministerial speeches and the fringe on topics close to our hearts. Read on for updates on the Lib Dem conference, West Streeting speech and Invest in Women Taskforce.